IBDEI0WE ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,15998,2)
 ;;=^84844
 ;;^UTILITY(U,$J,358.3,15999,0)
 ;;=250.80^^92^931^10
 ;;^UTILITY(U,$J,358.3,15999,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15999,1,4,0)
 ;;=4^250.80
 ;;^UTILITY(U,$J,358.3,15999,1,5,0)
 ;;=5^DM Type II with LE Ulcer
 ;;^UTILITY(U,$J,358.3,15999,2)
 ;;=DM Type II with LE Ulcer^267846^707.10
 ;;^UTILITY(U,$J,358.3,16000,0)
 ;;=250.00^^92^931^5
 ;;^UTILITY(U,$J,358.3,16000,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16000,1,4,0)
 ;;=4^250.00
 ;;^UTILITY(U,$J,358.3,16000,1,5,0)
 ;;=5^DM Type II Dm W/O Complications
 ;;^UTILITY(U,$J,358.3,16000,2)
 ;;=^33605
 ;;^UTILITY(U,$J,358.3,16001,0)
 ;;=250.40^^92^931^6
 ;;^UTILITY(U,$J,358.3,16001,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16001,1,4,0)
 ;;=4^250.40
 ;;^UTILITY(U,$J,358.3,16001,1,5,0)
 ;;=5^DM Type II Dm with Nephropathy
 ;;^UTILITY(U,$J,358.3,16001,2)
 ;;=^267837^583.81
 ;;^UTILITY(U,$J,358.3,16002,0)
 ;;=250.50^^92^931^9
 ;;^UTILITY(U,$J,358.3,16002,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16002,1,4,0)
 ;;=4^250.50
 ;;^UTILITY(U,$J,358.3,16002,1,5,0)
 ;;=5^DM Type II w/ PDR
 ;;^UTILITY(U,$J,358.3,16002,2)
 ;;=DM Type II w/ PDR^267839^362.02
 ;;^UTILITY(U,$J,358.3,16003,0)
 ;;=250.60^^92^931^7
 ;;^UTILITY(U,$J,358.3,16003,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16003,1,4,0)
 ;;=4^250.60
 ;;^UTILITY(U,$J,358.3,16003,1,5,0)
 ;;=5^DM Type II Dm with Neuropathy
 ;;^UTILITY(U,$J,358.3,16003,2)
 ;;=^267841^357.2
 ;;^UTILITY(U,$J,358.3,16004,0)
 ;;=250.70^^92^931^8
 ;;^UTILITY(U,$J,358.3,16004,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16004,1,4,0)
 ;;=4^250.70
 ;;^UTILITY(U,$J,358.3,16004,1,5,0)
 ;;=5^DM Type II Dm with Peripheral Vasc Dis
 ;;^UTILITY(U,$J,358.3,16004,2)
 ;;=^267843^443.81
 ;;^UTILITY(U,$J,358.3,16005,0)
 ;;=250.01^^92^931^4
 ;;^UTILITY(U,$J,358.3,16005,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16005,1,4,0)
 ;;=4^250.01
 ;;^UTILITY(U,$J,358.3,16005,1,5,0)
 ;;=5^DM Type I DM W/O Complications
 ;;^UTILITY(U,$J,358.3,16005,2)
 ;;=^33586
 ;;^UTILITY(U,$J,358.3,16006,0)
 ;;=272.0^^92^931^22
 ;;^UTILITY(U,$J,358.3,16006,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16006,1,4,0)
 ;;=4^272.0
 ;;^UTILITY(U,$J,358.3,16006,1,5,0)
 ;;=5^Hypercholesterolemia, Pure
 ;;^UTILITY(U,$J,358.3,16006,2)
 ;;=Hypercholesterolemia, Pure^59973
 ;;^UTILITY(U,$J,358.3,16007,0)
 ;;=272.1^^92^931^28
 ;;^UTILITY(U,$J,358.3,16007,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16007,1,4,0)
 ;;=4^272.1
 ;;^UTILITY(U,$J,358.3,16007,1,5,0)
 ;;=5^Hypertriglyceridemia, Pure
 ;;^UTILITY(U,$J,358.3,16007,2)
 ;;=Hypertriglyceridemia, Pure^101303
 ;;^UTILITY(U,$J,358.3,16008,0)
 ;;=272.2^^92^931^24
 ;;^UTILITY(U,$J,358.3,16008,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16008,1,4,0)
 ;;=4^272.2
 ;;^UTILITY(U,$J,358.3,16008,1,5,0)
 ;;=5^Hyperlipidemia, Mixed
 ;;^UTILITY(U,$J,358.3,16008,2)
 ;;=^78424
 ;;^UTILITY(U,$J,358.3,16009,0)
 ;;=275.42^^92^931^21
 ;;^UTILITY(U,$J,358.3,16009,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16009,1,4,0)
 ;;=4^275.42
 ;;^UTILITY(U,$J,358.3,16009,1,5,0)
 ;;=5^Hypercalcemia
 ;;^UTILITY(U,$J,358.3,16009,2)
 ;;=^59932
 ;;^UTILITY(U,$J,358.3,16010,0)
 ;;=275.41^^92^931^29
 ;;^UTILITY(U,$J,358.3,16010,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16010,1,4,0)
 ;;=4^275.41
 ;;^UTILITY(U,$J,358.3,16010,1,5,0)
 ;;=5^Hypocalcemia
 ;;^UTILITY(U,$J,358.3,16010,2)
 ;;=^60542
 ;;^UTILITY(U,$J,358.3,16011,0)
 ;;=276.7^^92^931^23
 ;;^UTILITY(U,$J,358.3,16011,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16011,1,4,0)
 ;;=4^276.7
 ;;^UTILITY(U,$J,358.3,16011,1,5,0)
 ;;=5^Hyperkalemia
 ;;^UTILITY(U,$J,358.3,16011,2)
 ;;=^60042
